RTW Investments’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-502,856
Closed -$11.4M 76
2024
Q3
$11.4M Hold
502,856
0.16% 52
2024
Q2
$9.78M Sell
502,856
-1,052,000
-68% -$20.5M 0.15% 50
2024
Q1
$58.4M Buy
1,554,856
+4,905
+0.3% +$184K 0.86% 35
2023
Q4
$86.7M Buy
1,549,951
+29,995
+2% +$1.68M 1.35% 24
2023
Q3
$62.7M Buy
1,519,956
+57,000
+4% +$2.35M 1.32% 22
2023
Q2
$81.7M Buy
1,462,956
+533,670
+57% +$29.8M 1.56% 22
2023
Q1
$51.8M Buy
929,286
+56,694
+6% +$3.16M 1.08% 25
2022
Q4
$31.8M Buy
872,592
+232,938
+36% +$8.49M 0.65% 34
2022
Q3
$18.2M Sell
639,654
-319,827
-33% -$9.11M 0.42% 41
2022
Q2
$43.4M Buy
959,481
+225,000
+31% +$10.2M 1.12% 30
2022
Q1
$55.9M Hold
734,481
1.16% 32
2021
Q4
$109M Hold
734,481
1.6% 23
2021
Q3
$107M Hold
734,481
1.61% 22
2021
Q2
$144M Buy
734,481
+22,966
+3% +$4.5M 2.17% 13
2021
Q1
$129M Buy
711,515
+50,582
+8% +$9.16M 2.01% 14
2020
Q4
$93.6M Hold
660,933
1.57% 20
2020
Q3
$82.4M Buy
660,933
+24,841
+4% +$3.1M 1.98% 16
2020
Q2
$56.8M Buy
636,092
+445,983
+235% +$39.8M 1.6% 23
2020
Q1
$11.8M Buy
190,109
+185,109
+3,702% +$11.5M 0.51% 40
2019
Q4
$381K Hold
5,000
0.01% 60
2019
Q3
$252K Buy
+5,000
New +$252K 0.02% 60